Visterra, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Visterra, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2007. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $149,990 in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $34 million sold in a notice filed in 2013.
Visterra at a glance
What does Visterra do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $149,990 in total (2016). NIH funding came from the National Institute on Drug Abuse.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $34.2 million sold (2013).
Frequently asked questions about Visterra
Where is Visterra headquartered?
Visterra, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Visterra do?
Visterra, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Visterra founded?
The earliest incorporation on record for Visterra, Inc. is in 2007, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
- Agios Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.